首页> 美国卫生研究院文献>Toxicology Reports >Downregulation of nicotinic and muscarinic receptor function in rats after subchronic exposure to diazinon
【2h】

Downregulation of nicotinic and muscarinic receptor function in rats after subchronic exposure to diazinon

机译:亚慢性暴露于二嗪农后大鼠烟碱和毒蕈碱受体功能的下调

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diazinon (DZN) is an organophosphate insecticide which exerts its effect through the inhibition of acetylcholinesterase enzyme (AChE). In this work, we studied the development of tolerance to subchronic p.o. administration of DZN in rats, under both in vivo and in vitro conditions. A group of 20 rats (2 groups, n = 10) was administered p.o. the 1/10 of established LD50 DZN (namely 55.87 mg/kg bw) for 28 days. On the 14th and 28th day of study with isolated diaphragm and ileum, we examined the downregulation of nicotinic and muscarinic receptor function through Electrical Field Stimulation (EFS). Maximum contractility of the diaphragm was recorded on the 14th day of the study (25% higher compared to the non-treated rats), while on the 28th day the contractions almost did not differ from the values found in non-treated rats. EFS of isolated ileum on the 14th day of study caused significantly higher contractions compared to the non-treated rats, but after 28 days, ileum contractions decreased approximately to the level of contractions in non-treated rats. On the 14th study day, we also recorded increased amplitude of spontaneous ileum contractions, compared to non-treated rats. The application of increasing ACh concentrations caused dose-dependent ileum contractions, without statistically significant differences of median effective concentration (EC50) values in non-treated and treated rats. Tolerance to subchronic DZN administration develops due to various adaptation mechanisms, including the most important one—downregulation of nicotinic and muscarinic receptor function.
机译:二嗪农(DZN)是一种有机磷杀虫剂,可通过抑制乙酰胆碱酯酶(AChE)发挥作用。在这项工作中,我们研究了对亚慢性p.o的耐受性的发展。在体内和体外条件下在大鼠体内施用DZN。口服给予一组20只大鼠(2组,n = 10)。建立的LD50 DZN的1/10(即55.87 mg / kg bw),持续28天。在隔离隔膜和回肠的研究的第14和28天,我们通过电场刺激(EFS)研究了烟碱和毒蕈碱受体功能的下调。在研究的第14天记录了the肌的最大收缩力(比未治疗的大鼠高25%),而在第28天,收缩率与未治疗的大鼠几乎没有差异。与未治疗的大鼠相比,在研究的第14天,离体回肠的EFS引起明显更高的收缩,但在28天后,回肠的收缩率大约降低到未治疗的大鼠的收缩水平。在第14个研究日,与未治疗的大鼠相比,我们还记录了自发性回肠收缩的幅度增加。 ACh浓度升高的应用导致剂量依赖性回肠收缩,而在未治疗和治疗的大鼠中,中位有效浓度(EC50)值无统计学显着差异。对亚慢性DZN给药的耐受性是由于多种适应机制而发展的,其中包括最重要的一种机制-烟碱和毒蕈碱受体功能的下调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号